Keyword: biologics

News

Aragen Launches First Phase of Biologics Facility in India

28.03.2024 -

Aragen, a CRDMO, has launched the first phase of its biologics manufacturing facility in Bangalore, India. The $30 million project, executed by its subsidiary Aragen...

News

Lonza Buys Biologics Plant From Roche for $1.2 Billion

21.03.2024 -

Lonza has signed an agreement to acquire Genentech's biologics manufacturing site in Vacaville, California (USA) from Roche. The Swiss pharmaceutical company announced...

News

Kyowa Kirin to Build First US Pharma Operations

12.03.2024 -

Japan-based pharmaceutical company Kyowa Kirin plans to build a $200 million biologics manufacturing center in Sanford, North Carolina, creating 102 jobs. This will be...

News

AbbVie to Build New Biologics Manufacturing Site in Singapore

30.01.2024 -

Last week, AbbVie broke ground on a new Singapore manufacturing facility located in Singapore's Tuas Biomedical Park. The company will invest $223 million in the site...

News

Merck Expands its Test Center for Biologics in Shanghai

28.11.2023 -

Merck has expanded its Biologics Testing Center in China with 1,500 m2 of new biosafety laboratories. The company is investing a total of €29 million in its testing...

News

Aragen to Invest $30 Million in a New Indian Bio-Manufacturing Site

31.10.2023 -

Aragen, an India, Hyderabad-headquartered contract research development and manufacturing organization (CRDMO) for small molecules and biologics, plans to set up a new...

Markets & Companies

New Biologics and Advanced Therapies

13.09.2023 -

The pharmaceutical market is undergoing a profound transformation, driven by innovation among biologics and advanced therapies (ATs). This shift is not only redefining...

Markets & Companies

Quality and Safety in Biopharmaceutical Production

13.09.2023 -

The biopharmaceutical industry is experiencing a drive towards biologic products due to their promise as treatments for chronic diseases.